Research / CW / Fundamental state Inspectable configuration
State dimensions Filing 0000026324-25-000023 General Corporate
Debt relative to revenue 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
118.99% · OPTIONAL · VALID
Capex intensity 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.96% · OPTIONAL · VALID
Operating cash generation 20th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-4.81% · OPTIONAL · VALID
Revenue growth 80th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
12.97% · CORE · VALID
Inventory pressure 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
71.76% · OPTIONAL · VALID
Gross margin 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
36.30% · CORE · VALID
Operating margin 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
16.04% · CORE · VALID
R&D intensity 15th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.86% · OPTIONAL · VALID
SBC intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.65% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 33.61%
Current 118.99%
Delta 85.38% Capex Intensity Increased
Previous 1.95%
Current 1.96%
Delta 0.00% Cash Generation Decreased
Previous 17.44%
Current -4.81%
Delta -22.25% Growth Increased
Previous 9.69%
Current 12.97%
Delta 3.27% Inventory Pressure Increased
Previous 17.35%
Current 71.76%
Delta 54.41% Margin Decreased
Previous 36.96%
Current 36.30%
Delta -0.66% Profitability Decreased
Previous 16.94%
Current 16.04%
Delta -0.90% R And D Intensity Decreased
Previous 2.94%
Current 2.86%
Delta -0.08% Sbc Intensity Increased
Previous 0.61%
Current 0.65%
Delta 0.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.